INVO Annual Revenue
$3.02 M
+$2.20 M+267.38%
31 December 2023
Summary:
As of January 23, 2025, INVO annual revenue is $3.02 million, with the most recent change of +$2.20 million (+267.38%) on December 31, 2023. During the last 3 years, it has risen by +$1.98 million (+191.20%).INVO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INVO Quarterly Revenue
$1.43 M
-$403.45 K-21.97%
30 September 2024
Summary:
As of January 23, 2025, INVO quarterly revenue is $1.43 million, with the most recent change of -$403.45 thousand (-21.97%) on September 30, 2024. Over the past year, it has dropped by -$143.15 thousand (-9.08%).INVO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INVO TTM Revenue
$6.23 M
+$458.25 K+7.94%
30 September 2024
Summary:
As of January 23, 2025, INVO TTM revenue is $6.23 million, with the most recent change of +$458.25 thousand (+7.94%) on September 30, 2024. Over the past year, it has increased by +$1.98 million (+46.58%).INVO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INVO Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +267.4% | -9.1% | +46.6% |
| 3 y3 years | +191.2% | +781.4% | +71.2% |
| 5 y5 years | +511.0% | +781.4% | +71.2% |
INVO Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -27.4% | -53.0% | at high |
INVO Bioscience Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.43 M(-22.0%) | $6.23 M(+7.9%) |
| June 2024 | - | $1.84 M(+16.5%) | $5.77 M(+35.8%) |
| Mar 2024 | - | $1.58 M(+14.1%) | $4.25 M(+40.7%) |
| Dec 2023 | $3.02 M(+267.4%) | $1.38 M(+41.7%) | $3.02 M(+57.6%) |
| Sept 2023 | - | $974.90 K(+208.6%) | $1.92 M(+62.8%) |
| June 2023 | - | $315.90 K(-9.2%) | $1.18 M(+16.9%) |
| Mar 2023 | - | $348.00 K(+25.1%) | $1.01 M(+22.6%) |
| Dec 2022 | $822.20 K(-80.2%) | $278.10 K(+18.2%) | $822.10 K(-77.1%) |
| Sept 2022 | - | $235.30 K(+61.1%) | $3.59 M(+0.5%) |
| June 2022 | - | $146.10 K(-10.1%) | $3.58 M(-1.7%) |
| Mar 2022 | - | $162.60 K(-94.7%) | $3.64 M(-12.5%) |
| Dec 2021 | $4.16 M(+301.1%) | $3.05 M(+1292.5%) | $4.16 M(+217.9%) |
| Sept 2021 | - | $218.90 K(+5.0%) | $1.31 M(-8.2%) |
| June 2021 | - | $208.50 K(-69.5%) | $1.43 M(-2.6%) |
| Mar 2021 | - | $684.50 K(+248.2%) | $1.46 M(+41.1%) |
| Dec 2020 | $1.04 M(-29.9%) | $196.60 K(-41.5%) | $1.04 M(-11.3%) |
| Sept 2020 | - | $336.10 K(+36.6%) | $1.17 M(+2.9%) |
| June 2020 | - | $246.10 K(-4.8%) | $1.14 M(-26.6%) |
| Mar 2020 | - | $258.60 K(-21.3%) | $1.55 M(+4.7%) |
| Dec 2019 | $1.48 M(+199.4%) | $328.60 K(+8.2%) | $1.48 M(+13.3%) |
| Sept 2019 | - | $303.60 K(-53.9%) | $1.31 M(+15.8%) |
| June 2019 | - | $658.60 K(+247.7%) | $1.13 M(+94.6%) |
| Mar 2019 | - | $189.40 K(+22.2%) | $579.60 K(+17.3%) |
| Dec 2018 | $494.40 K(+75.3%) | $155.00 K(+24.0%) | $494.30 K(+17.5%) |
| Sept 2018 | - | $125.00 K(+13.4%) | $420.70 K(+15.6%) |
| June 2018 | - | $110.20 K(+5.9%) | $363.90 K(+9.0%) |
| Mar 2018 | - | $104.10 K(+27.9%) | $334.00 K(+18.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $282.10 K(+454.2%) | $81.40 K(+19.4%) | $282.10 K(+34.2%) |
| Sept 2017 | - | $68.20 K(-15.1%) | $210.20 K(+31.5%) |
| June 2017 | - | $80.30 K(+53.8%) | $159.80 K(+88.2%) |
| Mar 2017 | - | $52.20 K(+449.5%) | $84.90 K(+67.1%) |
| Dec 2016 | $50.90 K(+335.0%) | $9500.00(-46.6%) | $50.80 K(+23.0%) |
| Sept 2016 | - | $17.80 K(+229.6%) | $41.30 K(+58.8%) |
| June 2016 | - | $5400.00(-70.2%) | $26.00 K(-0.8%) |
| Mar 2016 | - | $18.10 K(+624.0%) | $26.20 K(+123.9%) |
| Dec 2015 | $11.70 K(-29.5%) | - | - |
| Sept 2015 | - | $2500.00(-55.4%) | $11.70 K(+27.2%) |
| June 2015 | - | $5600.00(+55.6%) | $9200.00(+155.6%) |
| Mar 2015 | - | $3600.00(-5.3%) | $3600.00(-95.0%) |
| Dec 2014 | $16.60 K(-38.7%) | - | - |
| Dec 2013 | $27.10 K(-52.0%) | - | - |
| Dec 2012 | $56.40 K(-21.1%) | - | - |
| Dec 2011 | $71.50 K(+5.8%) | $3800.00(-70.5%) | $71.60 K(-26.6%) |
| Sept 2011 | - | $12.90 K(-40.8%) | $97.50 K(+15.2%) |
| June 2011 | - | $21.80 K(-34.1%) | $84.60 K(+14.3%) |
| Mar 2011 | - | $33.10 K(+11.4%) | $74.00 K(+9.3%) |
| Dec 2010 | $67.60 K(+7.0%) | $29.70 K(+165.2%) | $67.70 K(+41.6%) |
| June 2010 | - | $11.20 K(-58.2%) | $47.80 K(-10.2%) |
| Mar 2010 | - | $26.80 K(+288.4%) | $53.20 K(-15.8%) |
| Dec 2009 | $63.20 K(+66.3%) | $6900.00(+137.9%) | $63.20 K(+12.3%) |
| Sept 2009 | - | $2900.00(-82.5%) | $56.30 K(+5.4%) |
| June 2009 | - | $16.60 K(-54.9%) | $53.40 K(+45.1%) |
| Mar 2009 | - | $36.80 K | $36.80 K |
| Dec 2008 | $38.00 K | - | - |
FAQ
- What is INVO Bioscience annual revenue?
- What is the all time high annual revenue for INVO Bioscience?
- What is INVO Bioscience annual revenue year-on-year change?
- What is INVO Bioscience quarterly revenue?
- What is the all time high quarterly revenue for INVO Bioscience?
- What is INVO Bioscience quarterly revenue year-on-year change?
- What is INVO Bioscience TTM revenue?
- What is the all time high TTM revenue for INVO Bioscience?
- What is INVO Bioscience TTM revenue year-on-year change?
What is INVO Bioscience annual revenue?
The current annual revenue of INVO is $3.02 M
What is the all time high annual revenue for INVO Bioscience?
INVO Bioscience all-time high annual revenue is $4.16 M
What is INVO Bioscience annual revenue year-on-year change?
Over the past year, INVO annual revenue has changed by +$2.20 M (+267.38%)
What is INVO Bioscience quarterly revenue?
The current quarterly revenue of INVO is $1.43 M
What is the all time high quarterly revenue for INVO Bioscience?
INVO Bioscience all-time high quarterly revenue is $3.05 M
What is INVO Bioscience quarterly revenue year-on-year change?
Over the past year, INVO quarterly revenue has changed by -$143.15 K (-9.08%)
What is INVO Bioscience TTM revenue?
The current TTM revenue of INVO is $6.23 M
What is the all time high TTM revenue for INVO Bioscience?
INVO Bioscience all-time high TTM revenue is $6.23 M
What is INVO Bioscience TTM revenue year-on-year change?
Over the past year, INVO TTM revenue has changed by +$1.98 M (+46.58%)